Skip to main content

Table 2 Mean parameter estimates and bootstrap mean (95% confidence interval) estimates for the final covariate model

From: The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study

Parameter

Model

Bootstrap

 

Mean

Mean

95% confidence interval

   

2.5%

97.5%

Fixed effects

CL (L/h)

5.1

5.4

3.7

7.4

Vc (L)

18.7

18.2

13.0

21.0

Vp (L)

13.2

13.6

11.3

15.9

Q (L/h)

21.0

24.2

12.8

37.0

CLCRCL

1.89

1.85

0.99

2.65

Random effects BSV (% CV)

CL (L/h)

51.6

52.2

37.9

66.6

Vc (L)

45.8

48.4

32.1

69.9

Vp (L)

28.7

16.2

0.2

42.1

Random error

RUV (% CV)

13.7

13.3

10.1

17.6

RUV (SD, mg/L)

2.3

1.87

1.02

2.70

  1. CL, clearance; Vc, volume of distribution of the central compartment; Vp, volume of distribution of the peripheral compartment; Q, inter-compartmental clearance; CLCRCL, the fractional effect of CrCL on CL for patients not receiving RRT; BSV, between-subject variability; RUV, residual unexplained variability.